Icecure Medical Stock Analysis
| ICCM Stock | USD 0.57 0 0.61% |
IPO Date 26th of August 2021 | 200 Day MA 0.8689 | 50 Day MA 0.6471 | Beta 2.212 |
Icecure Medical holds a debt-to-equity ratio of 0.039. At this time, Icecure Medical's Short and Long Term Debt Total is very stable compared to the past year. As of the 17th of February 2026, Net Debt To EBITDA is likely to grow to 0.82, while Short and Long Term Debt is likely to drop about 2.6 M. Icecure Medical's financial risk is the risk to Icecure Medical stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Icecure Medical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Icecure Medical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Icecure Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Icecure Medical's stakeholders.
For many companies, including Icecure Medical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Icecure Medical, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Icecure Medical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 4.2744 | Enterprise Value Ebitda (2.63) | Price Sales 13.2131 | Shares Float 41.1 M | Wall Street Target Price 3.125 |
Icecure Medical is undervalued with Real Value of 1.19 and Target Price of 3.13. The main objective of Icecure Medical stock analysis is to determine its intrinsic value, which is an estimate of what Icecure Medical is worth, separate from its market price. There are two main types of Icecure Medical's stock analysis: fundamental analysis and technical analysis.
The Icecure Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Icecure Medical is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Icecure Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. Icecure Stock Analysis Notes
About 40.0% of the company shares are held by company insiders. The book value of Icecure Medical was currently reported as 0.14. The company recorded a loss per share of 0.25. Icecure Medical had not issued any dividends in recent years. The entity had 1011:992 split on the 9th of July 2025. IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation of tumors in the human body. The company was incorporated in 2006 and is headquartered in Caesarea, Israel. Icecure Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 55 people. To learn more about Icecure Medical call Eyal Shamir at 972 4 623 0333 or check out https://www.icecure-medical.com.Icecure Medical Quarterly Total Revenue |
|
Icecure Medical Investment Alerts
| Icecure Medical generated a negative expected return over the last 90 days | |
| Icecure Medical has some characteristics of a very speculative penny stock | |
| Icecure Medical has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 3.29 M. Net Loss for the year was (15.32 M) with profit before overhead, payroll, taxes, and interest of 1.04 M. | |
| Icecure Medical currently holds about 17.73 M in cash with (12.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.48. | |
| Icecure Medical has a frail financial position based on the latest SEC disclosures | |
| Roughly 40.0% of the company shares are held by company insiders | |
| Latest headline from prnewswire.com: IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense |
Icecure Largest EPS Surprises
Earnings surprises can significantly impact Icecure Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-11-19 | 2025-09-30 | -0.0539 | -0.06 | -0.0061 | 11 | ||
2024-11-26 | 2024-09-30 | -0.0726 | -0.08 | -0.0074 | 10 | ||
2024-08-20 | 2024-06-30 | -0.07 | -0.06 | 0.01 | 14 |
Icecure Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Efficient Wealth Management Llc | 2025-06-30 | 5 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 1.8 K | Bank Of America Corp | 2025-06-30 | 862 | Royal Bank Of Canada | 2025-06-30 | 500 | Bartlett & Co Wealth Management Llc | 2025-06-30 | 250 | Sbi Securities Co Ltd | 2025-06-30 | 3.0 | Tower Research Capital Llc | 2025-03-31 | 0.0 | Renaissance Technologies Corp | 2025-03-31 | 0.0 | Xtx Topco Ltd | 2025-06-30 | 0.0 | Citadel Advisors Llc | 2025-06-30 | 52.5 K | Geode Capital Management, Llc | 2025-06-30 | 40.5 K |
Icecure Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 39.31 M.Icecure Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.10) | (1.15) | |
| Return On Capital Employed | (2.00) | (2.10) | |
| Return On Assets | (1.10) | (1.15) | |
| Return On Equity | (2.55) | (2.42) |
Management Efficiency
Icecure Medical has return on total asset (ROA) of (0.6343) % which means that it has lost $0.6343 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5791) %, meaning that it created substantial loss on money invested by shareholders. Icecure Medical's management efficiency ratios could be used to measure how well Icecure Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 17th of February 2026, Return On Tangible Assets is likely to drop to -1.15. In addition to that, Return On Capital Employed is likely to drop to -2.1. At this time, Icecure Medical's Non Current Assets Total are very stable compared to the past year. As of the 17th of February 2026, Non Currrent Assets Other is likely to grow to about 66.2 K, while Total Assets are likely to drop about 12.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.16 | 0.15 | |
| Tangible Book Value Per Share | 0.16 | 0.15 | |
| Enterprise Value Over EBITDA | (2.86) | (3.01) | |
| Price Book Value Ratio | 7.30 | 7.66 | |
| Enterprise Value Multiple | (2.86) | (3.01) | |
| Price Fair Value | 7.30 | 7.66 | |
| Enterprise Value | 44 M | 59.2 M |
Icecure Medical showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Technical Drivers
As of the 17th of February 2026, Icecure Medical retains the Risk Adjusted Performance of (0.07), standard deviation of 3.16, and Market Risk Adjusted Performance of (0.19). Icecure Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Icecure Medical mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Icecure Medical is priced fairly, providing market reflects its last-minute price of 0.5735 per share. As Icecure Medical is a penny stock we also advise to confirm its jensen alpha numbers.Icecure Medical Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Icecure Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Icecure Medical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Icecure Medical Outstanding Bonds
Icecure Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Icecure Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Icecure bonds can be classified according to their maturity, which is the date when Icecure Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Icecure Medical Predictive Daily Indicators
Icecure Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Icecure Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Icecure Medical Forecast Models
Icecure Medical's time-series forecasting models are one of many Icecure Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Icecure Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Icecure Medical Bond Ratings
Icecure Medical financial ratings play a critical role in determining how much Icecure Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Icecure Medical's borrowing costs.| Piotroski F Score | 2 | Frail | View |
| Beneish M Score | (3.79) | Unlikely Manipulator | View |
Icecure Medical Debt to Cash Allocation
Many companies such as Icecure Medical, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Icecure Medical currently holds 459 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Icecure Medical has a current ratio of 4.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Icecure Medical's use of debt, we should always consider it together with its cash and equity.Icecure Medical Common Stock Shares Outstanding Over Time
Icecure Medical Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Icecure Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Icecure Medical Debt Ratio | 3.99 |
Icecure Medical Corporate Bonds Issued
Icecure Net Debt
About Icecure Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Icecure Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Icecure shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Icecure Medical. By using and applying Icecure Stock analysis, traders can create a robust methodology for identifying Icecure entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (4.19) | (4.40) | |
| Operating Profit Margin | (4.29) | (4.51) | |
| Net Loss | (4.19) | (4.40) | |
| Gross Profit Margin | 0.40 | 0.29 |
Current Icecure Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Icecure analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Icecure analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 3.13 | Strong Buy | 3 | Odds |
Most Icecure analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Icecure stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Icecure Medical, talking to its executives and customers, or listening to Icecure conference calls.
Icecure Stock Analysis Indicators
Icecure Medical stock analysis indicators help investors evaluate how Icecure Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Icecure Medical shares will generate the highest return on investment. By understating and applying Icecure Medical stock analysis, traders can identify Icecure Medical position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 10.5 M | |
| Common Stock Shares Outstanding | 50.9 M | |
| Total Stockholder Equity | 6.9 M | |
| Total Cashflows From Investing Activities | 446 K | |
| Property Plant And Equipment Net | 1.8 M | |
| Cash And Short Term Investments | 7.6 M | |
| Cash | 7.6 M | |
| Accounts Payable | 1.2 M | |
| Net Debt | -7.1 M | |
| 50 Day M A | 0.6471 | |
| Total Current Liabilities | 5.5 M | |
| Other Operating Expenses | 19 M | |
| Non Current Assets Total | 1.8 M | |
| Non Currrent Assets Other | 46 K | |
| Stock Based Compensation | 869 K |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Will Health Care Equipment & Supplies sector continue expanding? Could Icecure diversify its offerings? Factors like these will boost the valuation of Icecure Medical. Market participants price Icecure higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Icecure Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.25) | Revenue Per Share | Quarterly Revenue Growth 0.284 | Return On Assets | Return On Equity |
Understanding Icecure Medical requires distinguishing between market price and book value, where the latter reflects Icecure's accounting equity. The concept of intrinsic value - what Icecure Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Icecure Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Icecure Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.